NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
---|---|---|---|---|---|
1 | 09:00-09:08 | 09:00-09:08 | Symposium |
Incidence and predictors of weaning failure from VA-ECMO in patients with cardiogenic shock:an analysis of the Chinese extracorporeal life support registry |
Kexin Wang |
2 | 09:08-09:16 | 09:08-09:16 | Symposium |
Extracorporeal Membrane Oxygenation for Catastrophic Antiphospholipid Syndrome Complicated by Postcardiotomy Shock: A Case Report |
Wentao Bao |
3 | 09:16-09:24 | 09:16-09:24 | Symposium |
The Efficacy of Interventional Thrombectomy in ECMO-assisted High-risk Pulmonary Embolism: A Single-center Retrospective Propensity Score-Matched Cohort Study |
Jianyu Ji |
4 | 09:24-09:32 | 09:24-09:32 | Symposium |
Low Molecular Weight Heparin in Coagulation Management During ECPR: A Single-Center Experience |
Luobin Liang |
5 | 09:32-09:40 | 09:32-09:40 | Symposium |
Comparative Outcomes of Short-Term Versus Prolonged Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support: A Multicenter Analysis from the Chinese Extracorporeal Life Support Registry |
Yan Wang |
6 | 09:40-09:48 | 09:40-09:48 | Symposium |
Outcomes of DCD Heart Transplant Using Normothermic Regional Perfusion: A Systematic Review and Meta-analysis |
Xiaoqian Zhang |
7 | 09:48-09:56 | 09:48-09:56 | Symposium |
Development and Validation of a Predictive Model for Continuous Renal Replacement Therapy in Patients Undergoing Venovenous Extracorporeal Membrane Oxygenation |
Jinquan Xie |
8 | 09:56-10:04 | 09:56-10:04 | Symposium |
Interleukin-6 to lymphocyte count ratio in the prognosis of moderate to severe ARDS supported by Venovenous Extracorporeal Membrane Oxygenation: a single-center retrospective study |
Xiaojiao Tan |
9 | 10:04-10:12 | 10:04-10:12 | Symposium |
Establishment of a Predictive Scoring System for Unplanned Discontinuation of ECMO Combined with CRRT in Patients Receiving Regional Citrate Anticoagulation |
Nan Li |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
---|---|---|---|---|---|
1 | 10:00-10:08 | 10:00-10:08 | Symposium |
Mechanistic Study of Hypoxia-Induced Pulmonary Hypertension Mediating Neural Damage and Behavioral Abnormalities via HIF-1α/BDNF |
yuezhe shi |
2 | 10:08-10:16 | 10:08-10:16 | Symposium |
In-hospital outcomes of prophylactic versus emergent use of venous-arterial extracorporeal membrane oxygenation during transcatheter aortic valve implantation |
Huiruo Liu |
3 | 10:16-10:24 | 10:16-10:24 | Symposium |
The Impact of Left Heart Decompression on Venous-Arterial Extracorporeal Membrane Oxygenation in Infancy Patients After Cardiac Surgery:An Analysis of the Chinese Extracorporeal Life Support Registry |
Ruike Lu |
4 | 10:24-10:32 | 10:24-10:32 | Symposium |
Prognostic analysis of venoarterial extracorporeal membrane oxygenation for mechanical circulatory support in adults with Sepsis-related cardiomyopathy |
Xiaojiao Tan |
5 | 10:32-10:40 | 10:32-10:40 | Symposium |
A score prediction model for predicting VA ECMO 28-days survival: a multi-institutional, retrospective model development and validation study |
Yanping Li |
6 | 10:48-10:56 | 10:48-10:56 | Symposium |
A prediction nomogram for refractory septic shock children on ECMO support: A prospective cohort study |
Ye Cheng |
7 | 10:56-11:04 | 10:56-11:04 | Symposium |
The Practice of “ECMO specialist” nursing group model in neonatal ECMO |
Xiaoyan Sha |
8 | 11:04-11:12 | 11:04-11:12 | Symposium |
Linezolid Pharmacokinetics in Critically Ill ECMO Patients: Implications for Dosing Optimization |
Jiao Xie |